127 related articles for article (PubMed ID: 29069502)
41. Survival and level of care among breast cancer patients with brain metastases treated with whole brain radiotherapy.
Frisk G; Tinge B; Ekberg S; Eloranta S; Bäcklund LM; Lidbrink E; Smedby KE
Breast Cancer Res Treat; 2017 Dec; 166(3):887-896. PubMed ID: 28831636
[TBL] [Abstract][Full Text] [Related]
42. Reduction of overall treatment time in patients irradiated for more than three brain metastases.
Rades D; Kieckebusch S; Lohynska R; Veninga T; Stalpers LJ; Dunst J; Schild SE
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1509-13. PubMed ID: 17689033
[TBL] [Abstract][Full Text] [Related]
43. Does Graded Prognostic Assessment outperform Recursive Partitioning Analysis in patients with moderate prognosis brain metastases?
Estabrook NC; Lutz ST; Johnson CS; Lo SS; Henderson MA
CNS Oncol; 2016; 5(2):69-76. PubMed ID: 26985694
[TBL] [Abstract][Full Text] [Related]
44. Prediction of short survival in patients with brain metastases based on three different scores: a role for 'triple-negative' status?
Nieder C; Pawinski A; Molls M
Clin Oncol (R Coll Radiol); 2010 Feb; 22(1):65-9. PubMed ID: 19762219
[TBL] [Abstract][Full Text] [Related]
45. Outcomes after whole brain reirradiation in patients with brain metastases.
Son CH; Jimenez R; Niemierko A; Loeffler JS; Oh KS; Shih HA
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e167-72. PubMed ID: 21620583
[TBL] [Abstract][Full Text] [Related]
46. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
47. [Analysis of prognostic factors in 68 patients with cancer of unknown primary site].
Kou XG; Liang DL; Zhang QQ; Li XR; Zhao YZ; Gu JF; Lu P
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):783-6. PubMed ID: 22335913
[TBL] [Abstract][Full Text] [Related]
48. Whole brain radiotherapy: prognostic factors and results of a radiation boost delivered through a conventional linear accelerator.
Assouline A; Levy A; Chargari C; Lamproglou I; Mazeron JJ; Krzisch C
Radiother Oncol; 2011 May; 99(2):214-7. PubMed ID: 21620502
[TBL] [Abstract][Full Text] [Related]
49. Prognostic factors affecting the outcome of brain metastases from breast cancer.
Liu MT; Hsieh CY; Wang AY; Chang TH; Pi CP; Huang CC; Huang CY; Liou CH
Support Care Cancer; 2006 Sep; 14(9):936-42. PubMed ID: 16575571
[TBL] [Abstract][Full Text] [Related]
50. Radiation therapy for brain metastases from lung carcinoma. Prospective randomized trial according to the level of lactate dehydrogenase.
Chatani M; Matayoshi Y; Masaki N; Inoue T
Strahlenther Onkol; 1994 Mar; 170(3):155-61. PubMed ID: 8160096
[TBL] [Abstract][Full Text] [Related]
51. Short-course whole-brain radiotherapy (WBRT) for brain metastases due to small-cell lung cancer (SCLC).
Bohlen G; Meyners T; Kieckebusch S; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Rades D
Clin Neurol Neurosurg; 2010 Apr; 112(3):183-7. PubMed ID: 19962229
[TBL] [Abstract][Full Text] [Related]
52. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
[TBL] [Abstract][Full Text] [Related]
53. From whole brain to hospice: patterns of care in radiation oncology.
Stavas M; Arneson K; Friedman J; Misra S
J Palliat Med; 2014 Jun; 17(6):662-6. PubMed ID: 24673495
[TBL] [Abstract][Full Text] [Related]
54. [Radiation therapy for brain metastases from lung carcinoma: the second prospective randomized trial].
Chatani M; Matayoshi Y; Masaki N; Inoue T
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Dec; 54(14):1380-7. PubMed ID: 7596767
[TBL] [Abstract][Full Text] [Related]
55. Shorter-course whole-brain radiotherapy for brain metastases in elderly patients.
Rades D; Evers JN; Veninga T; Stalpers LJ; Lohynska R; Schild SE
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e469-73. PubMed ID: 21477949
[TBL] [Abstract][Full Text] [Related]
56. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
Rades D; Kueter JD; Pluemer A; Veninga T; Schild SE
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1077-81. PubMed ID: 18707817
[TBL] [Abstract][Full Text] [Related]
57. Prospective evaluation of the palliative effect of whole-brain radiotherapy in patients with brain metastases and poor performance status.
Komosinska K; Kepka L; Niwinska A; Pietrzak L; Wierzchowski M; Tyc-Szczepaniak D; Kaczmarczyk A; Bujko K
Acta Oncol; 2010 Apr; 49(3):382-8. PubMed ID: 20397770
[TBL] [Abstract][Full Text] [Related]
58. Stereotactic radiosurgery plus whole-brain radiotherapy for treatment of multiple metastases from non-small cell lung cancer.
Minniti G; Salvati M; Muni R; Lanzetta G; Osti MF; Clarke E; Costa A; Bozzao A; Trasimeni G; Enrici RM
Anticancer Res; 2010 Jul; 30(7):3055-61. PubMed ID: 20683055
[TBL] [Abstract][Full Text] [Related]
59. Prognostic factors for patients with advanced colorectal cancer and symptomatic brain metastases.
Tokoro T; Okuno K; Hida JC; Ueda K; Yoshifuji T; Daito K; Sugiura F
Clin Colorectal Cancer; 2014 Dec; 13(4):226-31. PubMed ID: 25442813
[TBL] [Abstract][Full Text] [Related]
60. The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis.
Buglione M; Pedretti S; Gipponi S; Buttolo L; Panciani P; Poliani PL; Liserre R; Borghetti P; Pegurri L; Costa L; Triggiani L; Pasinetti N; Ghirardelli P; Pandini S; Padovani A; Magrini SM;
Radiol Med; 2015 Dec; 120(12):1146-52. PubMed ID: 25917339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]